The Food and Drug Administration (FDA) is launching a new program to ramp up the United States’s domestic pharmaceutical ...

Because price and margin headwinds exist predominantly in small-molecule oral tablets that are easy to produce, we expect Viatris’ pipeline to focus more on complex generics—drugs that have complex ...

In line with the Trump administration’s goal to curb the United States’ reliance on overseas drug manufacturing, the FDA has ...

LipoVive is a particular weight loss supplement that recently caught my attention, not because of exaggerated promises ...

The Hemp Feed Coalition (HFC) announced a significant milestone with the inclusion of hemp seed meal (HSM) for laying hens in ...

Replimune Group's RP1 oncolytic virus therapy faced an FDA rejection, raising concerns about the platform's viability in ...

Free cash flow remained positive despite a $19.3 million inventory build; 2025 and 2026 guidance was reaffirmed for total revenue (more than $500 million and $625 million or more, respectively), ...

One of the most notable accomplishments of the first Trump Administration was its willingness to take on the status quo of ...

CMS often withholds coverage for reimbursement, disrupting the natural flow of the market and hindering access to proven ...

A new nuclear magnetic resonance method reveals real-time, coordinated changes in nanoemulsion drugs, improving noninvasive ...

The test, developed in part by Johns Hopkins researchers, will dramatically increase access to early detection and treatment ...

The early signs of Alzheimer's disease—more frequent memory loss, increased confusion—can be difficult to detect, often ...